메뉴 건너뛰기
Journal of the American Academy of Dermatology
Volumn 55, Issue 3, 2006, Pages 501-502
Sildenafil for the treatment of Raynaud's phenomenon

(1)  Heymann, Warren R a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBOPLATIN; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; TADALAFIL;
EID: 33747036138     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.037     Document Type: Article
Times cited : (8)
References (8)
  • 1
    • 27544509478 scopus 로고    scopus 로고
    • Understanding, assessing and treating Raynaud's phenomenon
    • Boin F., and Wigley F.M. Understanding, assessing and treating Raynaud's phenomenon. Curr Opin Rheumatol 17 (2005) 752-760
    • (2005) Curr Opin Rheumatol , vol.17 , pp. 752-760
    • Boin, F.1    Wigley, F.M.2
  • 2
    • 23944461780 scopus 로고    scopus 로고
    • Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis
    • Gore J., and Silver R. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Ann Rheum Dis 64 (2005) 1387
    • (2005) Ann Rheum Dis , vol.64 , pp. 1387
    • Gore, J.1    Silver, R.2
  • 3
    • 20644451217 scopus 로고    scopus 로고
    • Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis
    • Kamata Y., Kamimura T., Iwamoto M., and Minota S. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis. Clin Exp Dermatol 30 (2005) 451
    • (2005) Clin Exp Dermatol , vol.30 , pp. 451
    • Kamata, Y.1    Kamimura, T.2    Iwamoto, M.3    Minota, S.4
  • 4
    • 0037233987 scopus 로고    scopus 로고
    • Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al
    • author reply 283
    • Lichtenstein J.R. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al. Arthritis Rheum 48 (2003) 282-283 author reply 283
    • (2003) Arthritis Rheum , vol.48 , pp. 282-283
    • Lichtenstein, J.R.1
  • 5
    • 7244229635 scopus 로고    scopus 로고
    • Severe digital ischaemia treated with phosphodiesterase inhibitors
    • Kumana C.R., Cheung G.T., and Lau C.S. Severe digital ischaemia treated with phosphodiesterase inhibitors. Ann Rheum Dis 63 (2004) 1522-1524
    • (2004) Ann Rheum Dis , vol.63 , pp. 1522-1524
    • Kumana, C.R.1    Cheung, G.T.2    Lau, C.S.3
  • 6
    • 27744564115 scopus 로고    scopus 로고
    • Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy
    • Fries R., Shariat K., von Wilmowsky H., and Böhm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 112 (2005) 2980-2985
    • (2005) Circulation , vol.112 , pp. 2980-2985
    • Fries, R.1    Shariat, K.2    von Wilmowsky, H.3    Böhm, M.4
  • 7
    • 27744450610 scopus 로고    scopus 로고
    • More potential for sildenafil than potency
    • Mahler F., and Baumgartner I. More potential for sildenafil than potency. Circulation 112 (2005) 2894-2895
    • (2005) Circulation , vol.112 , pp. 2894-2895
    • Mahler, F.1    Baumgartner, I.2
  • 8
    • 19444381822 scopus 로고    scopus 로고
    • Use of tadalafil in a patient with secondary Raynaud's phenomenon not responding to sildenafil
    • Baumhaekel M., Scheffler P., and Boehm M. Use of tadalafil in a patient with secondary Raynaud's phenomenon not responding to sildenafil. Microvasc Res 69 (2005) 178-179
    • (2005) Microvasc Res , vol.69 , pp. 178-179
    • Baumhaekel, M.1    Scheffler, P.2    Boehm, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.